Kala Pharmaceuticals

About

Kala Pharmaceuticals develops novel treatments for diseases that affect mucosal tissues.

Waltham,Massachusetts,United States
101 - 250
http://www.kalarx.com

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $31M
Industries: Biotechnology,Health Care,Medical,Pharmaceutical
Founded date: Jan 1, 2009
Number Of Employee: 101 - 250
Operating Status: Active
Stock Symbol: nasdaq:KALA
Legal Name: Kala Pharmaceuticals Inc.
Also Known As: Kala

Kala Pharmaceuticals is developing novel treatments for diseases that affect mucosal tissues. The company's proprietary mucus penetrating particle technology dramatically improves drug distribution and pharmacokinetics by uniformly coating the mucosal surface with biocompatible, drug-loaded particles. Kala's formulations achieve high, sustained local drug concentrations with reduced systemic exposure and are delivered in a patient-friendly format. The company's research efforts have demonstrated successful in vivo proof-of-concept in mucosal organs such as the respiratory tract, eye, and cervicovaginal tract, enabling diverse product opportunities that target significant clinical unmet need. Kala is focused on advancing an internal pipeline of products through human proof-of-concept while establishing R&D collaborations with select partners to improve products in their pipelines.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

13

$627.36M

Kala Pharmaceuticals has raised a total of $627.36M in funding over 2 rounds. Their latest funding was raised on Nov 28, 2022 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 28, 2022	Post-IPO Equity	$31M	—	—	—	Detail
Nov 29, 2021	Post-IPO Equity	$16.12M	—	—	—	Detail
May 12, 2021	Post-IPO Debt	$125M	1	Oxford Finance LLC	—	Detail
Apr 6, 2020	Post-IPO Equity	$134M	—	—	—	Detail
Oct 3, 2018	Post-IPO Equity	$110M	1	Athyrium Capital Management LP	—	Detail

Investments

Number of Investments

Number of Lead Investments

3

0

Kala Pharmaceuticals has made 3 investments. Their most recent investment was on Dec 12, 2022, when Public Pressure raised $6M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 12, 2022 Public Pressure	Series Unknown	$6M	Blockchain	—
Jul 4, 2022 AltLayer	Seed	$7.20M	Blockchain	—
Jan 28, 2022 Astar Network	Series Unknown	$22M	Blockchain	—

Investors

Number of Lead Investors

Number of Investors

5

15

Kala Pharmaceuticals is funded by 15 investors. Oxford Finance LLC and Athyrium Capital Management LP are the most recent investors.

Investor Name	Lead Investor	Funding Round
Oxford Finance LLC	Yes	Post-IPO Debt
Athyrium Capital Management LP	Yes	Post-IPO Equity
Longitude Capital	Yes	Series C
Ysios Capital	Yes	Series B
CAM Capital	—	Series C
Lux Capital	—	Series C
OrbiMed	—	Series C
Polaris Partners	—	Series C
RA Capital Management	—	Series C
Vivo Capital	—	Series C